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Abstract
Background: Patients diagnosed with pulmonary embolism (PE) are reported to ex-
perience symptoms of posttraumatic stress disorder (PTSD) and existential anxiety 
following their diagnosis. They may also experience negative changes in perspective 
and hypervigilance of PE symptoms.
Objective: The aim of this study was to document the mental and emotional experi-
ence associated with PE diagnosis through the lens of PTSD, to better understand the 
factors involved in psychological distress following receipt of a PE diagnosis.
Patients/Methods: This was a mixed-methods study in two parts: (i) measurement 
of self-reported PTSD symptoms among patients attending thrombosis clinic and (ii) 
semistructured interviews with patients about their experience of receiving a diagno-
sis of PE and its psychological aftermath.
Results: Of 72 patients who participated in the survey, two met the criteria for a ten-
tative diagnosis of PTSD. The semistructured interviews with 37 patients suggested 
that around half of respondents experienced some degree of ongoing psychological 
distress. Those with psychological distress often recalled painful symptoms, recalled 
diagnosis delivery as stressful, worried about PE recurrence, and had anxieties about 
stopping their anticoagulant medication. Few patients reported inclination to seek 
support from professional mental health services.
Conclusions: We found ongoing and untreated psychological distress among people 
who were previously diagnosed with PE.
K E Y W O R D S
anxiety, posttraumatic, psychological distress, pulmonary embolism, stress disorders, 
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1  |  INTRODUC TION
Venous thromboembolism (VTE) presents as deep vein thrombosis 
(DVT) or pulmonary embolism (PE) and affects approximately 1 to 
2 per 1000 people per year.1,2 While untreated PE can be fatal, the 
risk of death decreases with treatment, and mortality rates have 
declined over the past 2 decades.3,4 Today, PE is a treatable and 
manageable condition with a low mortality rate, given timely diag-
nosis and appropriate anticoagulation therapy.5
While extensive research has been done regarding physio-
logical treatment for PE, many gaps remain in our understanding 
of patients’ psychological and emotional well-being following PE 
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diagnoses. Patients with PE have been shown to have higher de-
pression and anxiety scores compared to controls.6 Patients with PE 
also experience poor mental health as measured by health-related 
quality of life.7-9 For some, PE is regarded as a life-changing event 
that leads to a loss of identity, intrusive thoughts and memories, and 
a need to live a different lifestyle as a result of adapting to physical 
restraints.10 Impaired mental well-being in young adults with VTE 
has been linked largely to uncertainty regarding their long-term 
health and fear of recurrence.11,12 Other common themes reported 
by patients with VTE include insecurity in symptom management, 
perceived loss of immortality, negative changes in self-perception, 
and living in a constant state of alarm.13 Despite this evidence, there 
is little understanding of a mental health prognosis following PE, 
and we have yet to determine how treatment might improve patient 
mental health outcomes.
“Postthrombotic panic syndrome,” described by Hunter et al,14 
is a state of hypervigilance of physical reminders and sensations 
with cyclically triggered emotional and psychological distress. 
Existing literature of the psychological symptoms of PE, includ-
ing fear of recurrence, hypervigilance, flashbacks, and intrusive 
thoughts, all reveal symptoms suggestive of posttraumatic stress 
disorder (PTSD).10,14,15 This study explores the incidence of PTSD 
among patients with a prior diagnosis of PE and considers what 
factors might contribute to mental and emotional distress follow-
ing receipt of a PE diagnosis.
2  |  METHODS
Mixed-methods studies allow researchers to combine quantitative 
and qualitative research findings to further understand a condition. 
We chose this research approach because there is limited prior re-
search on psychological distress after a diagnosis of PE and very 
little on PTSD. We used mixed methods whereby we measured self-
reported symptoms relating to PTSD and then asked patients about 
the psychological effects of having a PE diagnosis during in-depth 
interviews. Use of qualitative research methods allowed participants 
to tell us about their personal experience. We did not test a research 
hypothesis. Instead, we used all the information recorded in these 
interviews to summarize, categorize, and look for patterns in patient 
experience.
2.1  |  Study population
Patients were recruited from a hospital thrombosis clinic in 
Hamilton, Ontario, over the months of May and June 2018. 
Patients were eligible for recruitment if they had a prior diagnosis 
of PE, were attending a scheduled appointment and were aged 18 
years or older. Patients were excluded if they had a diagnosis of 
DVT without PE, could not speak English, or had cognitive impair-
ment. Patients deemed eligible were invited to complete a brief 
survey about their emotional experiences after being diagnosed 
with PE, and if they were willing and had time, a short semistruc-
tured interview about their experiences following PE diagnosis. 
Ethics board approval for the research was obtained from the 
Hamilton Integrated Research Ethics Board.
2.2  |  Participant survey
The survey (see Appendix 1) opened with four statements on anxiety, 
low mood, coping, and worry. Respondents were asked to choose 
on a visual analogue scale (VAS) (0-100) the degree to which they 
agreed with each statement. A priori, we defined “agreement” with 
these statements as a VAS response of between 75 and 100. The re-
mainder of the survey was based on the PTSD Checklist for the 5th 
edition of the Diagnostic and Statistical Manual of Mental Disorders 
(PCL-5), available from the National Centre for Post-Traumatic Stress 
Disorder.16 Analysis of the PCL-5 involved summing the scores from 
the 20 items to reach a total score ranging between 0 and 80.17,18 
Our cut point for a tentative diagnosis of PTSD was 33.17,18 We also 
considered an alternative interpretation of the PCL-5 by reviewing 
clusters of symptoms within criteria B, C, D, and E. The survey was 
designed to take 5-10 minutes to complete and was self-adminis-
tered using a tablet computer. Formal consent was obtained through 
the tablet, and participants individually completed the survey within 
the clinic’s patient rooms. After giving consent and before complet-
ing the survey, demographic data including any comorbidities were 
also collected. Most patients who were eligible agreed to participate 
in the survey; however, we did not record the number of eligible pa-
tients who declined to participate.
2.3  |  Semistructured interviews
Patients who completed the survey were asked if they were will-
ing to be interviewed about their experience of having PE; consent 
was obtained for the interviews through a paper consent form. The 
semistructured interviews were designed to last around 30 min-
utes and were conducted in private patient rooms. Participants 
could have a friend or family member present if they wished. The 
Essentials
• Psychological symptoms can be seen after pulmonary 
embolism (PE).
• Among 72 patients with PE, we identified posttraumatic 
stress disorder in 3%.
• Around half experienced other ongoing psychological 
distress.
• Few patients had accessed mental health services.
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interviews had open-ended questions covering five main areas of 
interest (see Appendix 2): experience of receiving a PE diagnosis, 
psychological impact following PE diagnosis, lifestyle changes fol-
lowing diagnosis, changes in outlook on life, and past or current 
treatment. The interviews were audio recorded on a tablet com-
puter and subsequently transcribed verbatim. Each participant was 
given a pseudonym.
Each of the interview questions was treated as an interpreta-
tive theme19 such that the interviews were coded and summarized 
question by question. This process of summarizing was supported by 
the use of Microsoft Word, rather than specialist software designed 
to code qualitative data. Validated through cross-coding,20 these 
summaries were used to build up an image of what it was like, emo-
tionally, for these patients to receive a PE diagnosis and why some 
of them might subsequently have stressful PE-related experiences. 
This analysis process, essentially a content analysis,21 takes partic-
ipants’ accounts at face value.22 No attempt was made to explore 
how respondents rhetorically constructed their answers23 or how 
those answers might have been influenced by the interaction be-
tween interviewer and interviewee.24 We used anonymized extracts 
from the semistructured interviews (with pseudonyms) to illustrate 
our thematic findings. We followed the consolidated criteria for re-
porting qualitative studies.25
The interviews were conducted by AT, an undergraduate student 
with no prior medical knowledge and no prior relationship with the 
participants. She was guided in her analysis of the resulting data by 
MR, a male postdoctoral social scientist, and supported by KdW, a 
female emergency and thrombosis physician researcher who pro-
vided clinical knowledge of PE. At the outset, the authors acknowl-
edged their inherent biases and stances regarding the study topic. 
Neither AT nor MR had prior knowledge about venous thrombosis, 
however, KdW diagnosed PE in the emergency department and 
managed patients with PE in clinic. KdW came to this research study 
with the notion that some patients experienced more psychological 
distress than others after PE.
The data collection period, May to June 2018, was determined 
by AT’s availability to work full time on the research project. The 
sample was preset as all patients who accepted an invite to the sur-
vey and interview during this period.
3  |  RESULTS
Divided into two parts, we first present findings from the participant 
questionnaire and, second, from the semistructured interviews.
3.1  |  Participant questionnaire
Of the 75 patients who completed the survey, three survey partici-
pants met exclusion criteria, having been diagnosed with DVT alone 
and were excluded from the study. A total of 72 patients ranging 
from 28 to 85 years of age were included in our study; 45 (63%) were 
female, and the mean age was 65. The age and sex distribution can 
be seen in Figure 1. Fifteen percent were diabetic, 11% had coronary 
artery disease, 3% a history of stroke, 10% a history of depression, 
49% were also treated for cancer, and 10% had a history of chronic 
obstructive pulmonary disease. The median time since PE diagnosis 
was one year (ranging from before 2000 to 2018), and the median 
lifetime number of VTE events was one (ranging from one to four). 
Nineteen participants were within six months of PE diagnosis.
Figure 2 shows the VAS responses for each of the four statements 
on anxiety, low mood, ability to cope and worry, in a box-and-whisker 
plot. A quarter of people (n = 17) agreed that they felt more anxious 
since their PE diagnosis (using our predefined definition of 75-100 on 
the VAS), but very few people agreed with lower mood, impaired ability 
to cope, or an increase in worry since their diagnosis. Two of 72 patients 
(3%) had PCL-5 scores >33, which was our definition for PTSD diagnosis, 
17 of 72 patients (24%) scored a total score of 0 (see Appendix 3). The 
severity scores within criteria B, C, D, and E did not suggest an alternate 
F I G U R E  1  Age and sex distribution of 
survey respondents
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psychological pathology. Sex, age, and time since first PE diagnosis did 
not reveal patterns that suggested an association with PCL-5 scores.
3.2  |  Semistructured interviews
Thirty-seven participants agreed to be interviewed, all of whom had 
an interview (see Appendix 4 outlining age and sex of participants). 
The duration of the interviews ranged from 10 to 75 minutes and 
the age range of the interviewees was 28-85 years, with a mean age 
of 66. All patients were prescribed anticoagulant medications at the 
time of the interview. This sample was fairly evenly divided between 
those who reported no psychological distress following PE diagnosis 
(57%) and those who reported psychological distress (43%).
We found a number of themes associated with ongoing psycho-
logical distress: (i) physical symptoms, (ii) the way the diagnosis was 
explain or delivered by medical professionals at the time of diagno-
sis, and (iii) a reliance on anticoagulant medication.
3.2.1  |  Experience of PE symptoms
Those who did not experience distressing symptoms, feelings, or 
emotions at the time of their PE event generally considered their PE 
to be a nontraumatic event and did not commonly express ongoing 
psychological distress in relation to their PE.
For example, Mr Fitzwilliam was among those with no physical 
symptoms associated with his PE and places his diagnosis in the con-
text of other, ongoing health problems:
AT: So the cancer diagnosis in your case really over-
powered any other diagnosis you had?
Mr Fitzwilliam: Well, it’s more important to me, the 
cancer prognosis. The blood clot is nothing… it’s been 
a side issue.
AT: So you haven’t really thought about it at all.
Mr Fitzwilliam: No. (68-year-old man, page 2, line 70)
In contrast, Ms Clare describes psychological distress after her di-
agnosis. She recounted:
Ms Clare: I had very, very tight chest pains […] I was 
very dizzy and nauseous. The pain was radiating up to 
my neck and down my arms. I could feel it across my 
back, and I couldn’t take a deep breath. (49-year-old 
woman, page 2, line 9)
The bodily experiences of having PE and the emotional impact of 
receiving a diagnosis in which death was only narrowly avoided could, 
as Ms Pembroke recounts, be vividly relived:
Ms Pembroke: [It’s] something that’s always on the 
back of your mind. I went to [another country], […] 
and I flew there, so it was a very long flight, and I was 
on blood thinners. But still when I got there, I was 
extremely stressed that I was having another blood 
clot. I convinced myself that I was having one. And 
we were looking at hospitals and stuff. It was just in 
my head. So, I don’t know. I think it’s something that, 
F I G U R E  2  Self-reported anxiety, mood, coping and worry
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once you have it, it’s something that’s always in your 
mind. (28-year-old female, page 2, line 57)
3.2.2  |  Delivery and explanation of the PE diagnosis
Mr Emmanuel initially was not overly concerned when he first learnt 
about his PE diagnosis from a nurse:
Mr Emmanuel: I’ve had a couple in the leg before, 
so I wasn’t overly concerned until [the nurse] said, 
“is there anybody you’d like to call?” (laughs) They 
drew the curtains, and my wife is there. I’m having 
one heck of a time breathing. […] [The doctor] told 
me after, when I was leaving [the hospital], “a lot of 
people don’t get through this” […] I was one of the 
lucky ones. […] As the one doctor said, “this is a rare 
opportunity to talk to someone who made it through.” 
(laughs) (69-year-old man, page 1, line 21)
Mr Emmanuel attributes the change from not “overly concerned” 
about the PE to the realization that he is “one of the lucky ones,” 
to the behavior of the clinicians. The nurse asked him if there was 
anyone he wished to call, and the doctor said to him that a lot of 
people do not survive PE. Given that many patients have only a hazy 
knowledge of PE, participants’ recollection of the way in which their 
diagnosis was delivered could shape their impression and emotional 
response to PE.
And below, Ms Magdalene describes the emotional impact of re-
ceiving her diagnosis of PE:
Ms Magdalene: When [the doctor] said it was a blood 
clot, […] and it could go any minute, I could have a 
stroke, I could have a heart attack… […] that was a 
whole other ball game. […] That has got to be one 
of the most traumatic things in my life. (63-year-old 
woman, page 3, ln 121)
Among those people we interviewed, the physical, stressful sen-
sations of having PE (Mr Emmanuel’s experience of “having one heck 
of a time breathing”) coupled with the knowledge that events could 
have turned out differently (“I was one of the lucky ones”) were 
twin themes among those respondents who reported ongoing anx-
ieties. Diagnoses that were delivered calmly with explanations for 
the symptoms and information on PE treatment helped to minimize 
subsequent anxiety.
Ms Clare, for instance, suggested that “if there were 
more opportunities to have those educational ses-
sions, I think that would go a long way for explaining 
things to people. […] Now I know why I’m feeling what 
I’m feeling, it’s not happening again. I’m not going to 
die today, I’m okay! That just really reassured me.” 
(page 5, line 205)
3.2.3  |  Reliance on medication
It is striking that Ms Pembroke says that PE is always “on the back 
of your mind” or “in your mind.” However, in common with many 
of our respondents, she did not report making significant lifestyle 
changes. Rather than improving diet or increasing the amount of 
exercise they undertook, respondents reported that taking their 
anticoagulant medication had become an important part of their 
daily routines. The significance patients can give to taking their 
medication is illustrated below, in Ms Newnham’s account of why 
she did not stop her anticoagulated medication following a minor 
injury:
Ms Newnham: […] you’re so scared in case you miss 
a pill and your blood is gonna clot. […] you’re told to 
take a pill at 6 o’clock every day, you’re taking that pill! 
You don’t think if other things happen to ya. (81-year-
old woman, page 5, line 178)
Reports of adherence to anticoagulant medication were com-
mon in our sample, as were anxieties about stopping this medica-
tion. As Ms Kings noted, some patients considered their medication 
to be “lifesaving” and felt a sense of comfort in continuing with 
anticoagulation.
Ms Kings: It’s when you’re not treated […] that it can 
be serious. […] [The risk of bleeding] is a side effect 
that you put up with to take your life-saving medica-
tion. (45-year-old woman, page 2, line 50)
Our results did not suggest that cancer or other more serious 
health problems were a major factor in psychological distress. Our 
interview data showed varying levels of psychological distress 
among cancer patients within our sample. For example, in some 
cases, the presence of distressing PE symptoms contributed more 
than cancer to their long-term anxieties. In addition, neither our sur-
vey nor interviews identified patterns by participant sex, age, or time 
since PE diagnosis.
With respect to patients’ willingness to seek medical help for 
mental and emotional distress related to their PE diagnosis, our 
data are quite revealing. The survey data indicates that 64% of 
patients had not sought medical advice for their mental health. 
The interview data suggests a number of possible explanations 
for this: that PE was adequately managed by medication such that 
there was no need to feel anxious; that emotional distress was not 
brought up by clinicians, so therefore not discussed; and patients 
thought that psychological distress was not a topic to discuss with 
clinicians treating a physical condition. Those respondents who 
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reported speaking to their doctors about their feelings reported 
concerns about PE recurrence and the possibility that that recur-
rence could cause a stroke. A minority of respondents turned to 
family and friends for support.
4  |  DISCUSSION
Our study identified 2 of 72 people with experience of PE as hav-
ing a tentative diagnosis of PTSD. Although our sample is small, 
our findings suggest that PTSD does occur after diagnosis of PE, 
and our findings of PE-related anxiety signals that psychological 
distress occurs and may be going unaddressed. Our semistruc-
tured interview data revealed associations between: distress-
ing symptoms and fear of recurrence, diagnosis delivery and 
psychological distress, and psychological distress and focus on 
medication. Having psychologically distressing PE symptoms and 
receiving a diagnosis of PE, which almost inevitably comes with 
some physiological explanation of PE, can lead some patients to 
believe that they have narrowly escaped death. This troubling 
thought, a thought that can be reactivated by physical symptoms, 
real or imagined, can motivate adherence to regimes of anticoagu-
lant medication.
Prior research suggests that patients experience a great deal of 
psychological distress following their diagnosis and show symptoms 
that may be suggestive of PTSD.10,14,15 Less than half of our cohort 
described ongoing psychological distress. The existential anxiety, 
lost sense of identity,10 lost immortality, negative self-perception, 
and a need to adapt to a different lifestyle was not seen in our study 
participants.13 Instead, our participants reported symptom-related 
anxiety and fear of recurrent PE with attendant risks. Most felt no 
need to make significant lifestyle changes and reported simply add-
ing a routine of taking their medications. One thing to consider is 
the difference in inclusion and exclusion criteria, where the decision 
to exclude patients with cancer or those with severe comorbidities 
in other studies may have influenced how participants felt about 
their PE in relation to other existing health problems.10 The inclu-
sion of both DVT and PE in other qualitative studies may also have 
influenced how symptoms presented in these patients, and conse-
quently, how those diagnoses impacted their mental well-being.13,14 
Other studies followed patients at 6 months 14 or 5 years,10 measur-
ing shorter-term psychological repercussions, in contrast with our 
study sample, which included participants who had experienced PE 
up to 2 decades prior.
Our findings are more in keeping with those described in two 
recent qualitative studies (from Germany and Denmark).26,27 Like 
us, they found anxiety and distress, as well as a heightened aware-
ness of their bodily symptoms after being diagnosed with PE. 
These studies also reported instances where patients felt confu-
sion or discomfort when advised to discontinue their anticoagulant 
therapy.
Almost half of our participants recalled receiving their diag-
nosis of PE as a traumatic event, and these participants tended to 
experience ongoing psychological distress, often related to worries 
about possible PE recurrence. Our findings suggest that clinicians 
delivering a diagnosis of PE should be alert to this psychological im-
pact and avoid unnecessary reference to potential lethality. Practical 
information about the disease, clarifying that PE is unrelated to 
strokes and heart attacks, might be helpful. This lack of expert in-
formation, poor communication, or disjointed healthcare provision 
appears in relation to negative psychological effects following PE 
in almost all prior studies.10,14,26,27 Rapid access to expert care and 
advice should be considered a basic requirement for people who 
experience PE, and a first step toward mitigating the psychological 
distress.
Our findings raise important questions. What would be the best 
way to deliver the diagnosis of PE and how could patient follow-up 
more effectively alleviate the “back of mind anxieties”? These con-
siderations should lead to further research in this field.
There were limitations in our study design. Our sample size was 
limited, and our analysis of semistructured interview data took re-
spondents’ accounts at face value. Detailed information was not col-
lected on patients who declined to participate in the study. Selection 
bias may have influenced the prevalence of psychological distress or 
anxiety. Furthermore, 19 participants were within 6 months of their 
diagnosis, which is considered too early to diagnose PTSD. Though 
our data may be more specifically reflective of PE patients within 
Canada, and may not necessarily be transferrable to other countries, 
our mixed-methods study nonetheless provides useful material for 
critically reflecting on the mental and emotional distress that some 
patients experience following receipt of a PE diagnosis.
5  |  CONCLUSION
In this study, psychological distress was common after PE diagnosis. 
We found associations between ongoing psychological distress and 
the following: severe and distressing PE symptoms and fear of recur-
rent PE, traumatic diagnosis delivery, and emphasis on medication 
adherence.
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APPENDIX 2
Inter view quest ions
Experience of PE:_____________________________________________________________________
Can you describe what happened when you were diagnosed with a blood clot (PE)? [Interviewer will choose to use ‘blood clot’, ‘pulmonary 
embolism’ or ‘PE’ depending on patient familiarity and preference].
What thoughts went through your mind when you were told the diagnosis?
How did/do you feel?
Would you consider the PE to be a traumatic event or not?
If you could use three words to describe your experience of the PE, what would they be?
Psychological impact following PE diagnosis:______________________________________________
How were/are you emotionally or mentally impacted by the diagnosis?
For how long did you feel emotionally or mentally impacted?
Are there any component of the diagnosis that worry?
How has this impacted your family or loved ones?
How would you feel if you were to recall the time that you were diagnosed with the PE?
Perceived lifestyle changes:____________________________________________________________
How have you coped since your diagnosis?
Do you often feel the physical symptoms of PE?
Has the diagnosis impacted your ability to work?
How have your day-to-day routines or activities changed?
Do you now hesitate doing any activities you used to have no concerns with?
Perceived changes on outlook on life:_____________________________________________________
Has your outlook on life changed in any way?
Have you had any changes in perspective?
Do you feel your personality has changed?
Do you feel others see or treat you differently?
Perspective on past/current treatment:____________________________________________________
Are you satisfied with the treatment you’ve been given?
How do you think the blood thinners have helped you?
Do you think that the blood thinners have hindered you?
Do you believe additional psychological support should be offered to supplement your treatment?
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APPENDIX 3
PCL-5 score distr ibut ion (n=72)
Mean score 9, standard deviation 10; median 6, interquartile range 1-13.
APPENDIX 4
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